Writers' Community!
Home Page Two Columnists Submit an Article FAQs Contact Author Login
Article Submission
We Need YOUR Articles!
We'll Promote Them for FREE!

Author Login

New Authors
Register Here


Now Serving 5,555 Authors
50,490 Quality Articles
& 6,247 Current Users Online!
Featured Authors
Nicole Beurkens (189)
Mogama (10,829)
Jane Bullard (3,887)
Robert Melaccio, Sr. (6,290)
Terry Mitchell (2,651)
Susan Thom (9,051)
Rodney Biamby (94)
Michael Ramzy (156)
Aaron Taylor (958)
Ronyae (1,242)
Joel Hendon (10,620)
Mike Fak (9,489)
Joel Hirschhorn (994)
John Brazell (210)

View All Featured Authors
Most Recent
Investors Read This Before Jumping In Again!

Investing in Gold Bullion

Working Capital Model Investing The QDI

Gold Bullion

Stocks For 2009

Bullion trading

How Will Stock Markets Perform In 2009?

Collecting Old Pre-1920 Russian Gold Coins

German 20 Mark Gold Coin: A Stunning Old Rare German Coin

What Returns Should You Expect From Property?

Home » Categories » Finance » Investing » PPH Chart & Components » Printer Friendly

PPH Chart & Components

Rated 4.5 out of 5
No Reader Ratings Available ?
Rate It  /  View Comments  /  View All Articles submitted by Arthur Eckart
Submitted Sunday, October 02, 2005
Arthur Eckart (302)
PeakTrader.com
Log in to become a member of Arthur Eckart's Fan Club!


The PPH (Pharma Holders ETF) weekly three-year chart below shows a consolidation around 75, from October 1st 2002 to September 30th 2005. PPH began a rally in the previous three Octobers, and didn't stay below 70 for long. However, the Stochastics (Full STO) may indicate PPH will fall to around 68 in October before beginning another rally, and rise to above 75 within six months.

PPH consists of 21 big pharma stocks. Three components PFE JNJ and MRK represent 55% of the fund, and the eight largest components (shown below) represent 87% of the fund:

PFE 24%
JNJ 17%
MRK 14%
LLY 8%
ABT 8%
WYE 7%
BMY 6%
SGP 3%

PFE and MRK fell sharply in late 2004 on questions and lawsuits about one of their most profitable drugs. Moreover, the regulatory environment has been less favorable for the drug industry. Nonetheless, PFE earnings are expected to rise about 10%, while MRK earnings are expected to fall about 4%, over the next year. Earnings growth for the pharma industry is expected to outperform most other industries. Consequently, PPH is becoming cheaper, and it's more likely to rise sharply than in previous years.


Charts courtesy of StockCharts.com






Reprint Rights

Log in to become a member of Arthur Eckart's Fan Club!

Comments on this article:
No comments yet.


Was this article helpful to you? Leave a Public Comment or Question:

 

This Article has been viewed 295 times.
Article added to SearchWarp.com on Sunday, October 02, 2005
View other articles written by Arthur Eckart (302)


If you found this article interesting, you may want to check out:

Disclaimer:  All information on this site is provided for informational purposes only! By no means is any information presented herein intended to substitute for the advice provided to you by any health care or other professional or organization.


Today's Most Popular
Original Ways To Make Money Fast- She Made $20,000 in 3 Days

Where Does Money Come From ? Get ready for a shock if you don't already know.

Chicago Subsidized Apartments

Historical CD Rates Information

The Biggest Secret to Successful Currency Trading

Investors Read This Before Jumping In Again!

Forex Trading Times and Currency Relationships

The Art of Interpreting Japanese Candlesticks

Make Big Money With Autosurf In 5 Minutes a Day

Crude Oil – the Different Benchmarks For Traders and Investors

Home  |  Page Two  |  FAQ's  |  Contact  |  Terms of Service  |  Article Submission Guidelines  |  Writers' Contests  |  Privacy  |  Mission / About
Copyright © 1999-2009 SearchWarp.com, All Rights Reserved - SearchWarp.com is an IcoLogic, Inc. Company